129 related articles for article (PubMed ID: 8899256)
1. Pharmacodynamic effects of depot-medroxyprogesterone acetate (DMPA) administered to lactating women on their male infants.
Virutamasen P; Leepipatpaiboon S; Kriengsinyot R; Vichaidith P; Muia PN; Sekadde-Kigondu CB; Mati JK; Forest MG; Dikkeschei LD; Wolthers BG; d'Arcangues C
Contraception; 1996 Sep; 54(3):153-7. PubMed ID: 8899256
[TBL] [Abstract][Full Text] [Related]
2. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of levonorgestrel (LNG) administered either orally or subdermally to early postpartum lactating mothers on the urinary levels of follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (T) in their breast-fed male infants.
Shikary ZK; Betrabet SS; Toddywala WS; Patel DM; Datey S; Saxena BN
Contraception; 1986 Oct; 34(4):403-12. PubMed ID: 3096635
[TBL] [Abstract][Full Text] [Related]
4. Endometrial histology and circulating levels of medroxyprogesterone acetate (MPA), estradiol, FSH and LH in women with MPA induced amenorrhoea compared with women with secondary amenorrhoea.
Jeppsson S; Johansson ED; Ljungberg O; Sjöberg NO
Acta Obstet Gynecol Scand; 1977; 56(1):43-8. PubMed ID: 842303
[TBL] [Abstract][Full Text] [Related]
5. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
Paiva LC; Pinto-Neto AM; Faundes A
Contraception; 1998 Dec; 58(6):351-5. PubMed ID: 10095971
[TBL] [Abstract][Full Text] [Related]
6. Serum immunoglobulin levels during contraceptive use of depot-medroxyprogesterone acetate in Indian women: a preliminary study.
Lali P; Chandra L; Gupta RP
Contraception; 1996 Jun; 53(6):363-5. PubMed ID: 8773424
[TBL] [Abstract][Full Text] [Related]
7. Effects of hormonal and nonhormonal contraceptives on lactation and incidence of pregnancy.
Zacharias S; Aguilera E; Assenzo JR; Zanartu J
Contraception; 1986 Mar; 33(3):203-13. PubMed ID: 2941236
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of depot medroxyprogesterone acetate contraception.
Mishell DR
J Reprod Med; 1996 May; 41(5 Suppl):381-90. PubMed ID: 8725700
[TBL] [Abstract][Full Text] [Related]
9. Suppression of ovulation by a new subcutaneous depot medroxyprogesterone acetate (104 mg/0.65 mL) contraceptive formulation in Asian women.
Toh YC; Jain J; Rahnny MH; Bode FR; Ross D
Clin Ther; 2004 Nov; 26(11):1845-54. PubMed ID: 15639696
[TBL] [Abstract][Full Text] [Related]
10. Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user.
Dahlberg K
Int J Gynaecol Obstet; 1982 Feb; 20(1):43-8. PubMed ID: 6126406
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
[TBL] [Abstract][Full Text] [Related]
12. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.
McLachlan RI; O'Donnell L; Stanton PG; Balourdos G; Frydenberg M; de Kretser DM; Robertson DM
J Clin Endocrinol Metab; 2002 Feb; 87(2):546-56. PubMed ID: 11836283
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of children breast-fed by mothers receiving depot-medroxyprogesterone acetate.
Jimenez J; Ochoa M; Soler MP; Portales P
Contraception; 1984 Dec; 30(6):523-33. PubMed ID: 6241560
[TBL] [Abstract][Full Text] [Related]
14. Progestin-only methods safe during lactation.
Netw Res Triangle Park N C; 1993 Oct; 14(2):32-3. PubMed ID: 12287157
[TBL] [Abstract][Full Text] [Related]
15. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
Lei ZW; Wu SC; Garceau RJ; Jiang S; Yang QZ; Wang WL; Vander Meulen TC
Contraception; 1996 Jun; 53(6):357-61. PubMed ID: 8773423
[TBL] [Abstract][Full Text] [Related]
16. Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception.
Clark MK; Sowers M; Levy BT; Tenhundfeld P
Fertil Steril; 2001 May; 75(5):871-7. PubMed ID: 11334896
[TBL] [Abstract][Full Text] [Related]
17. Serum follicle-stimulating hormone, luteinizing hormone and progesterone concentrations in pseudopregnant rats treated with medroxyprogesterone acetate.
de Greef WJ; Dullaart J; Zeilmaker GH
J Endocrinol; 1976 Sep; 70(3):465-71. PubMed ID: 978105
[TBL] [Abstract][Full Text] [Related]
18. Return of ovulation following a single injection of depo-medroxyprogesterone acetate: a pharmacokinetic and pharmacodynamic study.
Lan PT; Aedo AR; Landgren BM; Johannisson E; Diczfalusy E
Contraception; 1984 Jan; 29(1):1-18. PubMed ID: 6234145
[TBL] [Abstract][Full Text] [Related]
19. Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial.
Nanda K; Callahan R; Taylor D; Wang M; Agot K; Jenkins D; Van Damme L; Dorflinger L;
Contraception; 2016 Jul; 94(1):40-7. PubMed ID: 26972780
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
Taneepanichskul S; Intaraprasert S; Theppisai U; Chaturachinda K
Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
